Black Rock Inc. Atara Biotherapeutics, Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Atara Biotherapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 6,831,479 shares of ATRA stock, worth $58.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,831,479

Previous 7,087,213 3.61%

Holding current value

$58.1 Million

Previous $3.61 Million 30.41%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$0.44 - $1.22 $112,522 - $311,995	-255,734 Reduced 3.61%	6,831,479 $4.71 Million
Q4 2023 Feb 13, 2024	SELL	$0.23 - $1.74 $140,006 - $1.06 Million	-608,722 Reduced 7.91%	7,087,213 $3.61 Million
Q3 2023 Nov 13, 2023	SELL	$1.41 - $2.31 $799,912 - $1.31 Million	-567,314 Reduced 6.87%	7,695,935 $11.4 Million
Q2 2023 Aug 11, 2023	SELL	$1.5 - $3.04 $1.51 Million - $3.06 Million	-1,008,049 Reduced 10.87%	8,263,249 $13.3 Million
Q1 2023 May 12, 2023	BUY	$2.8 - $5.46 $333,617 - $650,553	119,149 Added 1.3%	9,271,298 $26.9 Million

Q4 2022 Feb 13, 2023	BUY	$2.85 - $5.18 $684,450 - $1.24 Million	240,158 Added 2.69%	9,152,149 $30 Million
Q3 2022 Nov 14, 2022	BUY	$2.85 - $8.73 $419,762 - $1.29 Million	147,285 Added 1.68%	8,911,991 $33.7 Million
Q2 2022 Aug 12, 2022	BUY	$4.69 - $9.84 $4.52 Million - $9.49 Million	964,567 Added 12.37%	8,764,706 $68.3 Million
Q1 2022 May 12, 2022	SELL	$8.44 - $16.89 $138,525 - $277,215	-16,413 Reduced 0.21%	7,800,139 $72.5 Million
Q4 2021 Feb 10, 2022	BUY	$14.7 - $19.89 $2.42 Million - $3.28 Million	164,961 Added 2.16%	7,816,552 $123 Million
Q3 2021 Nov 09, 2021	SELL	$11.99 - $17.9 $820,595 - $1.23 Million	-68,440 Reduced 0.89%	7,651,591 $137 Million
Q2 2021 Aug 11, 2021	BUY	$12.89 - $16.58 $99.5 Million - $128 Million	7,720,031 New	7,720,031 $120 Million

Others Institutions Holding ATRA

# of Institutions

Shares Held

85M

Call Options Held

18.4K

Put Options Held

51.3K

View Full List

About Atara Biotherapeutics, Inc.

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $802M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

More about ATRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account